Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Denatured collagen matrix in dentin refers to the structurally altered or unfolded form of the collagen component within the dentin extracellular matrix, typically resulting from processes such as caries (tooth decay), acid exposure, heat, or other insults[1][3]. In its healthy state, dentin collagen is primarily type I and forms a triple helical structure that provides important mechanical and structural support to dental tissues[4][6]. When denatured, the triple helix is disrupted; cross-linkages disappear, and the collagen becomes more susceptible to enzymatic breakdown, particularly by collagenases and matrix metalloproteinases (MMPs)[1][3]. Denatured collagen in dentin is most commonly found in the outer layer of carious lesions (caries-infected dentin), making this zone physically degradable and unsuitable for remineralization or durable dental adhesive bonding[1]. There are no drugs that selectively target the denatured collagen matrix for therapeutic intervention, but dental materials scientists are investigating cross-linkers and other modifiers to stabilize denatured collagen during restorative procedures[1][3]. In dental materials research, the presence and extent of denatured collagen can be detected and quantified using collagen hybridizing peptide (CHP) staining[1][3].
Null (collagen cross-linkers and inhibitors may stabilize or protect denatured matrix but are not "targeting" drugs in the strict sense)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Denatured collagen matrix in dentin.